2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Vilobelimab.
Journal: Clinical Infectious Diseases : An Official Publication Of The Infectious Diseases Society Of America
Published:
Abstract
This article provides a focused update to the clinical practice guideline on the treatment and management of patients with COVID-19, developed by the Infectious Diseases Society of America. The guideline panel presents a recommendation on the use of vilobelimab in hospitalized adults with critical COVID-19. The recommendation is based on evidence derived from a systematic literature review and adheres to a standardized methodology for rating the certainty of evidence and strength of recommendation according to the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) approach.
Authors
Nandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, Kathleen Chiotos, Amy Dzierba, Arthur Kim, Greg Martin, Jeffrey Pearson, Amy Shumaker, Lindsey Baden, Roger Bedimo, Vincent Cheng, Kara Chew, Eric Daar, David Glidden, Erica Hardy, Steven Johnson, Jonathan Li, Christine Macbrayne, Mari Nakamura, Laura Riley, Robert Shafer, Shmuel Shoham, Pablo Tebas, Phyllis Tien, Jennifer Loveless, Yngve Falck Ytter, Rebecca Morgan, Rajesh Gandhi
Relevant Conditions